Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Livonibe 200mg Tablet
Manufacturer/Marketed By : BDR PHARMACEUTICALS INT PVT LTD
$67.09 $36.46
Livonibe 200mg Tablet belongs to the group of medicines called anti-cancer. It consists of the active ingredient Sorafenib which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular...
SORAFENIB
Active Pharmaceutical Ingredient
Livonibe 200mg Tablet
$67.09
$36.46
Livonibe 200mg Tablet belongs to the group of medicines called anti-cancer. It consists of the active ingredient Sorafenib which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery, and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy. Diarrhea, tiredness, stomach pain, nausea, weakness, rashes, flu-like illness, appetite loss, nausea, weight loss, and low blood calcium levels are common side effects of Livonibe 200mg Tablet. Inform your doctor if any of these side effects disturb or persist with you. Inform your doctor if you are allergic to this Tablet and its ingredients. Before starting treatment with this tablet, you should tell your physician if you have heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. Use effective contraception during the therapy and for 6 months after the last dose if you are a woman or 3 months after the last dose if you are a man.
Active Pharmaceutical Ingredient
Uses
• Advanced renal cell carcinoma
• Advanced hepatocellular carcinoma that cannot be surgically treated
• Advanced papillary and follicular Hurtle cell thyroid carcinoma
Benefits
Livonibe 200mg Tablet works by inhibiting multiple receptor tyrosine kinases (enzymes), primarily vascular endothelial growth factor receptors and platelet-derived growth factor-β receptors. This prevents the development of blood vessels in tumor cells (angiogenesis) and arrests the growth and spread of the tumor cells to other organs.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Nausea, stomach pain, diarrhea
• Tiredness and weakness
• Infection
• Hair thinning and patchy hair loss
• Rash
• Weight loss
• Loss of appetite
• Low levels of calcium in the blood
• Flu-like illness
Common Side Effects
• Stevens Johnsons Syndrome and toxic epidermal necrosis
• Decreased blood flow to the heart
• Increased risk of bleeding (blood in urine, stool, vomit, cough, etc.)
• High BP
• Skin problems
• Liver problems
• Problems in wound healing
How To Use
Take the Livonibe 200 mg tablet without food (1 hour before or 2 hours after a meal). Swallow with a glass of water. Do not break, crush or chew the tablets.
Safety Advice
• Breast Feeding: Do not breastfeed during treatment with Livonibe 200mg Tablet and for two weeks after the last dose. It is vital to let your physician know if you are breastfeeding or planning to breastfeed before starting treatment with this drug.
• Alcohol: Avoid drinking alcohol while taking Livonibe 200mg Tablet as it can cause unpleasant side effects like drowsiness, dizziness, or difficulty in concentrating.
• Liver: Livonibe 200 mg tablet should be taken with caution in patients with severe liver disease. Consult your doctor for advice.
• Lungs: Livonibe 200 mg tablet should be cautiously administered in patients with certain lung problems. Consult your doctor if you have any lung disorders.
• Driving: This medicine could cause peripheral sensory neuropathy that causes an impact on driving. Hence, avoid driving or doing things that require focus during this treatment period.
• Pregnancy: It is unsafe to use Livonibe 200mg Tablet during pregnancy as it may harm the unborn baby. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant. Your physician will conduct a pregnancy test before prescribing this medicine.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.